Plexus (NASDAQ:PLXS) Releases Earnings Results, Beats Expectations By $0.19 EPS

Plexus (NASDAQ:PLXS) issued its earnings results on Wednesday. The technology company reported $2.32 EPS for the quarter, beating analysts’ consensus estimates of $2.13 by $0.19, FiscalAI reports. The business had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.23 billion. Plexus had a return on equity of 12.57% and a net margin of 4.03%.Plexus’s revenue was up 28.2% on a year-over-year basis. During the same period in the prior year, the company posted $1.64 earnings per share. Plexus updated its Q4 2026 guidance to 2.470-2.630 EPS.

Plexus Price Performance

Shares of NASDAQ:PLXS traded up $11.98 on Friday, hitting $253.97. The stock had a trading volume of 151,862 shares, compared to its average volume of 337,192. Plexus has a twelve month low of $124.49 and a twelve month high of $307.06. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.54. The firm’s 50 day moving average price is $273.64 and its 200-day moving average price is $233.69. The company has a market capitalization of $6.80 billion, a price-to-earnings ratio of 37.48 and a beta of 0.88.

Insider Activity

In related news, insider Michael J. Running sold 510 shares of Plexus stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $272.17, for a total transaction of $138,806.70. Following the completion of the transaction, the insider directly owned 665 shares of the company’s stock, valued at $180,993.05. This trade represents a 43.40% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Angelo Michael Ninivaggi, Jr. sold 3,270 shares of the business’s stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $264.75, for a total transaction of $865,732.50. Following the completion of the transaction, the executive vice president owned 16,266 shares in the company, valued at approximately $4,306,423.50. This trade represents a 16.74% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 20,481 shares of company stock worth $5,519,183. Company insiders own 1.78% of the company’s stock.

Hedge Funds Weigh In On Plexus

Institutional investors and hedge funds have recently bought and sold shares of the business. Inspire Investing LLC increased its stake in Plexus by 1.6% in the fourth quarter. Inspire Investing LLC now owns 3,178 shares of the technology company’s stock valued at $467,000 after purchasing an additional 50 shares in the last quarter. Maryland State Retirement & Pension System grew its stake in shares of Plexus by 1.5% in the 4th quarter. Maryland State Retirement & Pension System now owns 3,940 shares of the technology company’s stock valued at $579,000 after buying an additional 60 shares during the period. Corient Private Wealth LLC grew its stake in shares of Plexus by 4.5% in the 4th quarter. Corient Private Wealth LLC now owns 1,900 shares of the technology company’s stock valued at $279,000 after buying an additional 82 shares during the period. Smartleaf Asset Management LLC increased its position in Plexus by 13.6% in the 4th quarter. Smartleaf Asset Management LLC now owns 916 shares of the technology company’s stock valued at $137,000 after buying an additional 110 shares in the last quarter. Finally, Inceptionr LLC raised its stake in Plexus by 4.2% during the 4th quarter. Inceptionr LLC now owns 3,624 shares of the technology company’s stock worth $533,000 after buying an additional 145 shares during the period. Institutional investors and hedge funds own 94.45% of the company’s stock.

Analysts Set New Price Targets

PLXS has been the subject of a number of analyst reports. Raymond James Financial reaffirmed an “outperform” rating and set a $275.00 price objective on shares of Plexus in a report on Thursday, April 30th. Wall Street Zen raised shares of Plexus from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Zacks Research raised shares of Plexus from a “strong sell” rating to a “hold” rating in a research report on Monday, July 13th. Stifel Nicolaus raised their price target on shares of Plexus from $280.00 to $330.00 and gave the stock a “buy” rating in a research note on Monday, June 22nd. Finally, Weiss Ratings raised Plexus from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday, July 6th. Six analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $273.00.

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.